313 related articles for article (PubMed ID: 15250020)
1. The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments.
Rolston KV
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S44-8. PubMed ID: 15250020
[TBL] [Abstract][Full Text] [Related]
2. Management of fever in neutropenic patients with different risks of complications.
Klastersky J
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S32-7. PubMed ID: 15250018
[TBL] [Abstract][Full Text] [Related]
3. Initial empirical antimicrobial therapy: duration and subsequent modifications.
Tamura K
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S59-64. PubMed ID: 15250024
[TBL] [Abstract][Full Text] [Related]
4. Monotherapy versus dual therapy based on risk categorization of febrile neutropenic patients.
Ohyashiki K
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S56-8. PubMed ID: 15250023
[TBL] [Abstract][Full Text] [Related]
5. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
Jarque I; Sanz MA
Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary.
Masaoka T
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S49-52. PubMed ID: 15250021
[No Abstract] [Full Text] [Related]
7. [Management of febrile neutropenic patients].
Takata T; Tamura K
Gan To Kagaku Ryoho; 2006 Jan; 33(1):13-8. PubMed ID: 16410691
[TBL] [Abstract][Full Text] [Related]
8. Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia.
Rolston KV
Clin Infect Dis; 2005 Apr; 40 Suppl 4():S246-52. PubMed ID: 15768330
[TBL] [Abstract][Full Text] [Related]
9. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
10. [Antimicrobial prophylaxis and therapy in neutropenia].
Link H
Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
[TBL] [Abstract][Full Text] [Related]
11. Perspectives for the management of febrile neutropenic patients with cancer in the 21st century.
Sipsas NV; Bodey GP; Kontoyiannis DP
Cancer; 2005 Mar; 103(6):1103-13. PubMed ID: 15666328
[TBL] [Abstract][Full Text] [Related]
12. Empirical antimicrobial treatment for chemotherapy-induced febrile neutropenia.
Bal AM; Gould IM
Int J Antimicrob Agents; 2007 May; 29(5):501-9. PubMed ID: 17346939
[TBL] [Abstract][Full Text] [Related]
13. Management of the febrile neutropenic patient.
Picazo JJ;
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S120-2; discussion S133-40. PubMed ID: 16243492
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society).
Link H; Böhme A; Cornely OA; Höffken K; Kellner O; Kern WV; Mahlberg R; Maschmeyer G; Nowrousian MR; Ostermann H; Ruhnke M; Sezer O; Schiel X; Wilhelm M; Auner HW; ;
Ann Hematol; 2003 Oct; 82 Suppl 2():S105-17. PubMed ID: 13680173
[TBL] [Abstract][Full Text] [Related]
15. Febrile neutropenia in haematological malignancies.
Sharma A; Lokeshwar N
J Postgrad Med; 2005; 51 Suppl 1():S42-8. PubMed ID: 16519255
[TBL] [Abstract][Full Text] [Related]
16. Management of the febrile neutropenic patient: a consensus conference.
Picazo JJ
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S1-6. PubMed ID: 15250013
[No Abstract] [Full Text] [Related]
17. Antimicrobial prophylaxis in febrile neutropenia.
Yoshida M; Ohno R
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S65-7. PubMed ID: 15250025
[TBL] [Abstract][Full Text] [Related]
18. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
Klastersky J
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KV; Ramsey SD
J Clin Oncol; 2013 Feb; 31(6):794-810. PubMed ID: 23319691
[TBL] [Abstract][Full Text] [Related]
20. Combination and single-agent empirical antibacterial therapy for febrile cancer patients with neutropenia and mucositis.
Shenep JL
NCI Monogr; 1990; (9):117-22. PubMed ID: 2342588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
